Product
YS-0N-001
1 clinical trial
1 indication
Indication
CancerClinical trial
Phase 1, Open Label, Dose Escalation and Cohort Expansion Study of YS-ON-001 in Patients With Advanced Solid TumorsStatus: Completed, Estimated PCD: 2019-12-15
1 clinical trial
1 indication